The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
PO Box 32
Lincolnshire, IL 60069
The Campaign Urging Research for Eosinophilic Disease (CURED) 501(c)(3) mission is to raise substantial funding to aid in research and public awareness for this complex disease. Although the number of people diagnosed with this disease is on the rise, very little is known about eosinophilic disorder. CURED supports and encourages research, and provides other services including patient advocacy and networking. Eosinophils are a type of white blood cell, and eosinophilic disorders are disorders that are characterized by the presence of above-normal numbers of eosinophils. Symptoms vary widely, depending on the area affected, but may include nausea, vomiting, diarrhea, failure to thrive, chest pain, difficulty swallowing, poor appetite, and anemia, among others.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.